Number of the records: 1  

Incidence of intravenous drug incompatibilities in intensive care units

  1. 1.
    0437509 - ÚTIA 2016 RIV CZ eng J - Journal Article
    Machotka, O. - Maňák, J. - Kuběna, Aleš Antonín - Vlček, J.
    Incidence of intravenous drug incompatibilities in intensive care units.
    Biomedical Papers. Roč. 159, č. 4 (2015), s. 652-656. ISSN 1213-8118. E-ISSN 1804-7521
    Institutional support: RVO:67985556
    Keywords : medical error * graph theory * graph coloring * drug administration * drug incompatibilities * applied combinatorics * decision theory * medical * medication safety * intensive care units
    Subject RIV: FN - Epidemiology, Contagious Diseases ; Clinical Immunology
    Impact factor: 0.924, year: 2015
    http://library.utia.cas.cz/separaty/2014/E/kubena-0437509.pdf

    Drug incompatibilities are relatively common in inpatients and this may result in increased morbidity/mortality as well as add to costs. The aim of this 12 month study was to identify real incidences of drug incompatibilities in intravenous lines in critically ill patients in two intensive care units (ICUs). Methods: A prospective cross sectional study of 82 patients in 2 ICUs, one medical and one surgical in a 1500-bed university hospital. One monitor carried out observations during busy hours with frequent drug administration. Patients included in both ICUs were those receiving at least two different intravenous drugs. Results: 6.82% and 2.16% of drug pairs were found to be incompatible in the two ICUs respectively. The study showed that a significant number of drug incompatibilities occur in both medical and surgical ICUs. It follows that the incidence of incompatibilities could be diminished by adhering to a few simple rules for medication administration, following by recommendations for multiple lumen catheter use
    Permanent Link: http://hdl.handle.net/11104/0241892

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.